Providers

Increasing air pollution and climate change have an impact on respiratory health and mortality, explained speakers in 2 sessions on the environment and respiratory diseases at the European Respiratory Society International Congress 2021.

Gefapixant successfully improved quality-of-life and reduced cough severity for patients with chronic cough vs placebo, according to 2 posters.

Researchers have found that the COVID-19 pandemic has caused potentially millions of children to miss routine vaccines. During a time of back-to-school excitement and reversals of transmission prevention efforts in some states, children may be at risk of facing a slew of non-COVID-19 viral outbreaks.

Health care and research need to do a better job of taking into account sex and gender differences that can affect disease, healthy behaviors, and care delivery, according to speakers at the European Respiratory Society International Congress 2021.

On this episode of Managed Care Cast, we speak with one of the authors of a recent book looking at the erosion of trust in health care, the factors that influence trust, and what can be done to restore trust.

The Department of Justice vows to protect access to abortions amid restrictive legislation; wide distribution of Pfizer’s COVID-19 booster shot is expected to begin the week of September 20; adult residents from states that lifted eviction moratoriums exhibit increased risk of COVID-19 infection.

On January 1, CMS implemented the Hospital Price Transparency final rule, but by July, it was clear that many hospitals were noncompliant. Even with a proposed rule for penalties, requirements still only fall on certain parts of the health care industry.

Dual bronchodilators have been shown to broadly improve symptoms and quality of life (QOL) in patients with chronic obstructive pulmonary disease (COPD).

During the pandemic, interest in home monitoring grew, and research has shown it can be feasible for patients with interstitial lung disease, according to a presentation at the European Respiratory Society International Congress 2021.

The chief of medical oncology and hematology at Bryn Mawr Hospital and associate principal investigator for Main Line Health's NCI Community Oncology Research Program discusses therapeutic advances along with ongoing challenges in enrolling patients with small cell lung cancer (SCLC) in clinical trials.

Using the argument that regularly taking medication is a great way to earn parents' trust is a great tactic to encourage children and teenagers to remain adherent to their asthma therapies, said William "Andy" Nish, MD, an allergist and immunologist in Georgia.

Hepatocellular carcinoma (HCC) is challenging to diagnose and has an evolving treatment landscape, which makes a multidisciplinary approach to care important to ensure high-quality care and the best patient outcomes.

The approval of zanubrutinib makes it just the second therapy indicated for this rare type of lymphoma.

Highlighting the latest ophthalmology-related news reported across MJH Life Sciences™.

The findings of this study suggest possible poor communication about human papillomavirus infection (HPV), the authors said, since they do not align with epidemiologic evidence.

A new Texas law ending abortions after 6 weeks takes effect, angering the American College of Obstetricians and Gynecologists; the CDC says mortality rates may not go back to normal until 2023; a Senate version of a bill aimed at lowering drug prices would only impact Medicare.

The European Respiratory Society International Congress 2021 will feature a wide array of topics, such as gender and respiratory health, the impact of climate change, and management and treatment of chronic cough, but there remains a strong focus on the COVID-19 pandemic, its intersection with respiratory care and treatment of infection.

In 1989, in Atlanta, Georgia, Dázon Dixon Diallo established SisterLove Inc to fill the information and education gap many women, especially Black women, were facing on how the emerging HIV/AIDS epidemic could affect them.

Two people dead after receiving potentially contaminated Moderna COVID-19 vaccines in Japan; Biogen offers its controversial and expensive Alzheimer disease treatment for free to boost prescriptions; COVID-19 infection with the Delta variant may more than double the risk of hospitalization.

Rajesh Rajpal, MD, chief medical officer, global head of clinical medical affairs, Johnson & Johnson Vision, discusses how greater visual needs are contributing to adverse eye health in younger populations.

The 5-year update could help solidify the role of sodium glucose co-transporter 2 (SGLT2) inhibitors in treating heart failure, years after the first evidence of their effectiveness emerged.

Foundation Medicine and Epic struck a deal to integrate comprehensive genomic profiling within Epic's electronic health records (EHRs), allowing for providers to order and review genomic profiling tests, leading to more streamlined clinical decision making.

Survey responses from patients with advanced cancer revealed that there were gaps in knowledge across various aspects of immunotherapy treatment, including about side effects and curative potential.

Postoperative management of deep brain stimulation in patients with Parkinson disease was shown to be safe and effective when administered at home, which may reduce necessity of in-clinic visits and care access issues.

Pfizer's COVID-19 vaccine has gained full approval from the FDA.

COVID-19 booster associated with significantly improved protection against infection in at-risk adults aged 60 and older; spotlighting health risks of climate change for farmworkers; uninsured rate remains stable despite pandemic.

Findings of the PANORAMA randomized clinical trial show that when patients with severe nonproliferative diabetic retinopathy were treated with intravitreal aflibercept, severity improved over 100 weeks and the likelihood of vision-threatening complications significantly reduced.

An overview of the latest news in Parkinson disease (PD) reported across MJH Life Sciences™.

The findings suggest that people who inject drugs living with HIV need ongoing support with an emphasis on taking medication for opioid use disorder.

A review of therapies for atopic dermatitis (AD) found adequate net health benefit for new treatments. However, safety remains a concern for the Janus kinase (JAK) inhibitors.